Pennsylvania tightens control on xylazine, animal sedative linked to opioid overdoses.
TL;DR
Pennsylvania will classify xylazine, a powerful veterinary sedative that has been mixed with fentanyl in the state's opioid supply, as a Schedule III drug. This will allow for tighter record keeping, storage requirements, and prosecution for illegal possession and sale. Nitazenes, a class of synthetic opioids, will also be classified as a Schedule I narcotic. Xylazine contributed to 575 overdose deaths across 30 counties in 2021, and Philadelphia reported that 90% of street opioid samples contained the drug.
Topics:nationhealth#drug-classification#health#opioid-epidemic#pennsylvania#substance-abuse#xylazine
- Pennsylvania will classify xylazine as a schedule III drug, Gov. Shapiro announces The Philadelphia Inquirer
- Animal sedative contributed to drug-related deaths, officials say 69News WFMZ-TV
- States restrict 'tranq,' animal sedative linked to overdoses WTAE Pittsburgh
- Pennsylvania takes steps to limit access to powerful sedative contributing to opioid overdoses WGAL Susquehanna Valley Pa.
- Xylazine, an animal tranquilizer found mixed with opioids, classified as a controlled substance in Pennsylvania CBS News
- View Full Coverage on Google News
Want the full story? Read the original reporting
Read on The Philadelphia Inquirer